Novo Nordisk spends up to $1.64bn on US biotech startups
Pharmaceutical Technology
JANUARY 7, 2024
Novo Nordisk taps Flagship Pioneering portfolio companies Omega Therapeutics and Cellarity as obesity drugs competition intensifies.
Pharmaceutical Technology
JANUARY 7, 2024
Novo Nordisk taps Flagship Pioneering portfolio companies Omega Therapeutics and Cellarity as obesity drugs competition intensifies.
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 7, 2024
A study suggests eating later in the day can directly impact our biological weight regulation in three key ways: through the number of calories that we burn; our hunger levels; and the way our bodies store fat.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JAMA Internal Medicine
JANUARY 7, 2024
This cohort study assesses the prevalence, underlying causes, and harms of diagnostic errors among hospitalized adults who died or were transferred to intensive care.
pharmaphorum
JANUARY 7, 2024
Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound, opening up a new direct-to-consumer (DTC) channel that
Fierce Pharma
JANUARY 7, 2024
Less than six months after Ligand Pharmaceuticals swooped in to buy Novan’s assets following the latter company’s bankruptcy, the purchase has paid off with an FDA approval. | Less than six months after Ligand Pharmaceuticals swooped in to buy Novan’s assets following the latter company’s bankruptcy, the purchase has paid off with an FDA approval.
Drug Patent Watch
JANUARY 7, 2024
Annual Drug Patent Expirations for LAZANDA Lazanda is a drug marketed by Btcp Pharma and is included in one NDA. There are five patents protecting this drug. This drug has… The post New patent expiration for Btcp Pharma drug LAZANDA appeared first on DrugPatentWatch - Make Better Decisions.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
JAMA Internal Medicine
JANUARY 7, 2024
This Viewpoint examines the similarities between medical errors and COVID-19 and discusses lessons applicable to ongoing and emerging health challenges.
Pharma in Brief
JANUARY 7, 2024
On January 5, 2024, the US Food and Drug Administration ( FDA ) approved Florida’s proposal to import prescription drugs from Canada. This is the first approval of a Section 804 Importation Program ( SIP ) by the FDA. Whether Florida is able to import drugs from Canada, including in light of Canadian regulations controlling drug exports, remains to be seen.
Pharmaceutical Commerce
JANUARY 7, 2024
The immediate availability, flexibility, and cutting-edge technology of rental cold storage units make them a popular solution for pharmaceutical cold chain challenges.
JAMA Internal Medicine
JANUARY 7, 2024
This cohort study assesses whether there has been an increase in measures of hospital inpatient complexity in British Columbia, Canada, over a 15-year period.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Drug Patent Watch
JANUARY 7, 2024
This chart shows the pharmaceutical companies with the most patents in Hong Kong. Patents must be filed in each country (or, in some cases regional patent office) where patent protection… The post Which pharmaceutical companies have the most drug patents in Hong Kong? appeared first on DrugPatentWatch - Make Better Decisions.
Let's personalize your content